Multicomponent crystals of gliclazide and tromethamine: preparation, physico-chemical, and pharmaceutical characterization^*

References

• Palmer KJ, Brogden RN. Gliclazide. An update of its pharmacological properties and therapeutic efficacy in non-insulin-dependent diabetes mellitus. Drugs. 1993;85:92–125.
   Google Scholar
• Del Guerra S, D’Aleo V, Lupi R, et al. Effects of exposure of human islet beta-cells to normal and high glucose levels with or without gliclazide or glibenclamide. Diabetes Metab. 2009;35:293–298.
   PubMed Web of Science ®Google Scholar
• Maggi L, Canobbio A, Bruni G, et al. Improvement of the dissolution behavior of gliclazide, a slightly soluble drug, using solid dispersions. J Drug Deliv Sci Technol. 2015;26:17–23.
   Web of Science ®Google Scholar
• Varshosaz J, Talari R, Mostafavi SA, et al. Dissolution enhancement of gliclazide using in situ micronization by solvent change method. Powder Technol. 2008;187:222–230.
   Web of Science ®Google Scholar
• Biswal S, Sahoo J, Murthy PN, et al. Enhancement of dissolution rate of gliclazide using solid dispersions with polyethylene glycol 6000. AAPS PharmSciTech. 2008;9:563–570.
   PubMed Web of Science ®Google Scholar
• Biswal S, Sahoo J, Murthy PN. Physicochemical properties of solid dispersions of gliclazide in polyvinylpyrrolidone K90. AAPS PharmSciTech. 2009;10:329–334.
   PubMed Web of Science ®Google Scholar
• Jyothirmai G, Nageswara Rao VV. Solubility enhancement of gliclazide by solid dispersion technique. Int J Inv Pharm Sci. 2013;1:542–553.
   Google Scholar
• Ambrogi V, Perioli L, Ciarnelli V, et al. Effect of gliclazide immobilization into layered double hydroxide on drug release. Eur J Pharm Biopharm. 2009;73:285–291.
   PubMed Web of Science ®Google Scholar
• Putra OD, Yonemochi E, Uekusa H. Isostructural multicomponent gliclazide crystals with improved solubility. Cryst Growth Des. 2016;16:6568–6573.
   Web of Science ®Google Scholar
• Chadha R, Rani D, Goyal P. Novel cocrystals of gliclazide: characterization and evaluation. CrystEngComm. 2016;18:2275–2283.
   Web of Science ®Google Scholar
• Radi A-E, Eissa S. Electrochemical study of gliclazide and its complexation with b-cyclodextrin. Electroanalysis. 2010;22:2991–2996.
   Web of Science ®Google Scholar
• Abdelkader H, Abdallah OY, Salem HS. Comparison of the effect of tromethamine and polyvinylpyrrolidone on dissolution properties and analgesic effect of nimesulide. AAPS PharmSciTech. 2007;8:E1–E8.
   PubMed Web of Science ®Google Scholar
• McEvoy GK. American Hospital Formulary Service. AHFS drug information. Bethesda (MD): American Society of Health-System Pharmacists; 2007. p. 2647.
   Google Scholar
• Vishweshwar P, McMahon JA, Bis JA, et al. Pharmaceutical co-crystals. J Pharm Sci. 2006;95:499–511.
   PubMed Web of Science ®Google Scholar
• Schultheiss N, Newman N. Pharmaceutical cocrystals and their physicochemical properties. Cryst Growth Des. 2009;9:2950–2967.
   PubMed Web of Science ®Google Scholar
• Bruni G, Maietta M, Berbenni V, et al. Preparation and characterization of carprofen co-crystals. CrystEngComm. 2012;14:435–445.
   Web of Science ®Google Scholar
• Bruni G, Maietta M, Maggi L, et al. An experimental and theoretical investigation of loperamide hydrochloride-glutaric acid co-crystals. J Phys Chem B. 2013;117:8113–8121.
   PubMedGoogle Scholar
• Bruni G, Maietta M, Maggi L, et al. Preparation and physico-chemical characterization of acyclovir co-crystals with improved dissolution properties. J Pharm Sci. 2013;102:4079–4086.
   PubMed Web of Science ®Google Scholar
• Duggirala NK, Perry ML, Almarsson O, et al. Pharmaceutical cocrystals: along the path to improved medicines. ChemComm. 2016;52:640–655.
   PubMed Web of Science ®Google Scholar
• Bak A, Gore A, Yanez E, et al. The co-crystal approach to improve the exposure of a water-insoluble compound: AMG 517 sorbic acid co-crystal characterization and pharmacokinetics. J Pharm Sci. 2008;97:3942–3956.
   PubMed Web of Science ®Google Scholar
• Ross SA, Lamprouand DA, Douroumis D. Engineering and manufacturing of pharmaceutical co-crystals: a review of solvent-free manufacturing technologies. ChemComm. 2016;52:8772–8786.
   PubMed Web of Science ®Google Scholar
• Weyna DR, Shattock T, Vishweshwar P, et al. Synthesis and structural characterization of cocrystals and pharmaceutical cocrystals: mechanochemistry vs slow evaporation from solution. Cryst Growth Des. 2009;9:1106–1123.
   Web of Science ®Google Scholar
• Heiden S, Trobs L, Wenzel KJ, et al. Mechanochemical synthesis and structural characterization of a theophylline-benzoic acid cocrystal (1:1). CrystEngComm. 2012;14:5128–5129.
   Web of Science ®Google Scholar
• James SL, Adams CJ, Bolm C, et al. Mechanochemistry: opportunities for new and cleaner synthesis. Chem Soc Rev. 2012;41:413–447.
   PubMed Web of Science ®Google Scholar
• Davin T, Leigh L, Tomislav F. Towards medicinal mechanochemistry: evolution of milling from pharmaceutical solid form screening to the synthesis of active pharmaceutical ingredients (APIs). Chem Commun. 2016;52:7760–7781.
   PubMed Web of Science ®Google Scholar
• Braga D, Grepioni F, André V, et al. Drug-containing coordination and hydrogen bonding networks obtained mechanochemically. CrystEngComm. 2009;11:2618–1621.
   Web of Science ®Google Scholar
• Bruni G, Maietta M, Berbenni V, et al. Mechanochemical synthesis of bumetanide−4-aminobenzoic acid molecular cocrystals: a facile and green approach to drug optimization. J Phys Chem B. 2014;118:9180–9190.
   PubMed Web of Science ®Google Scholar
• Winter CS, Shields L, Timmins P, et al. Solid-state properties and crystal structure of gliclazide. J Pharm Sci. 1994;83:300–304.
   PubMed Web of Science ®Google Scholar
• Santa Maria D, Claramunt RM, Alkorta I, et al. The behavior of gliclazide in solution and in the solid state: a case of organic compound presenting a solid-solution structure. Magn Reson Chem. 2009;47:472–477.
   PubMed Web of Science ®Google Scholar